GEORGETTE NADEAU: Open Payments
NPI 1770065781 · TALENT, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 23 payments from 10 companies in 2025. Trend: 2023 $74 · 2024 $267 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $106 |
| Novo Nordisk Inc | 4 | $72 |
| Lundbeck LLC | 3 | $69 |
| Exact Sciences Corporation | 3 | $63 |
| Astellas Pharma US Inc | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Amgen Inc. | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REXULTI, CREON, Ozempic, The Cologuard Plus Collection Kit, Veozah, MOUNJARO, QULIPTA, OTEZLA.
Industry payments across OR — which companies pay providers there.
